Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT00510887 · TERMINATED
Trial details
- NCT number
- NCT00510887
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.